P8IP
RCKT icon

Pier 88 Investment Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Pier 88 Investment Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Buy
54,200
+6,320
+13% +$25.1K 0.05% 106
2025
Q4 		$168K Buy
47,880
+36,500
+321% +$125K 0.04% 108
2025
Q3 		$37.1K Hold
11,380
– – 0.01% 112
2025
Q2 		$27.9K Sell
11,380
-45,440
-80% -$230K 0.01% 102
2025
Q1 		$379K Buy
56,820
+19,320
+52% +$191K 0.07% 92
2024
Q4 		$471K Buy
37,500
+5,010
+15% +$75.4K 0.09% 80
2024
Q3 		$600K Buy
32,490
+1,590
+5% +$32.6K 0.13% 66
2024
Q2 		$665K Buy
30,900
+12,900
+72% +$296K 0.15% 73
2024
Q1 		$485K Hold
18,000
– – 0.12% 65
2023
Q4 		$539K Hold
18,000
– – 0.14% 59
2023
Q3 		$369K Buy
+18,000
New +$327K 0.09% 83

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pier 88 Investment Partners's RCKT Position: Q1 2026 in Review

Pier 88 Investment Partners increased its Rocket Pharmaceuticals (RCKT) stake by 13% in Q1 2026, buying an estimated $25.1K and bringing the position to 54,200 shares worth $194K. The position accounts for 0.05% of the portfolio, ranked #106.

Pier 88 Investment Partners first reported a position in RCKT in Q3 2023 and has held it in 11 quarters since. The position peaked at $665K in Q2 2024. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Pier 88 Investment Partners held 54,200 shares of Rocket Pharmaceuticals worth $194K as of Q1 2026.
  • Pier 88 Investment Partners bought 6,320 Rocket Pharmaceuticals shares in Q1 2026, an estimated $25.1K.
  • Rocket Pharmaceuticals made up 0.05% of Pier 88 Investment Partners's portfolio in Q1 2026, its #106 holding.
  • Pier 88 Investment Partners first reported a position in Rocket Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • Pier 88 Investment Partners's Rocket Pharmaceuticals position peaked at $665K in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Pier 88 Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.